An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation

Completed · Phase 3

Conditions studied: Smoking Cessation

In brief

Open-label comparison of standard 12-week regimen of varenicline with standard 10-week regimen of transdermal nicotine patch for smoking cessation.

Key facts

Study ID

NCT00143325

Run by

Pfizer

People needed

730

Starts

2005-01-01

Expected to finish

2006-06-01

Last updated by the study team

2007-06-04

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must have smoked an average of at least 15 cigarettes per day during the past year and over the month prior to the screening visit, with no period of abstinence greater than 3 months in the past year.

You may not qualify if…

• Subjects with clinically significant cardiovascular disease in the past 6 months.

Where it is running

• Pfizer Investigational Site — Palo Alto, California, United States
• Pfizer Investigational Site — Santa Ana, California, United States
• Pfizer Investigational Site — Farmington, Connecticut, United States
• Pfizer Investigational Site — Lexington, Kentucky, United States
• Pfizer Investigational Site — Worcester, Massachusetts, United States
• Pfizer Investigational Site — Portland, Oregon, United States
• Pfizer Investigational Site — Brussels, Belgium
• Pfizer Investigational Site — Edegem, Belgium
• Pfizer Investigational Site — Ghent, Belgium
• Pfizer Investigational Site — Caen, France
• Pfizer Investigational Site — Clermont-Ferrand, France
• Pfizer Investigational Site — Limeil-Brévannes, France
• Pfizer Investigational Site — Metz, France
• Pfizer Investigational Site — Paris, France
• Pfizer Investigational Site — Vandœuvre-lès-Nancy, France
• Pfizer Investigational Site — Amsterdam, Netherlands
• Pfizer Investigational Site — Enschede, Netherlands
• Pfizer Investigational Site — Maastricht, Netherlands
• Pfizer Investigational Site — Zutphen, Netherlands
• Pfizer Investigational Site — London, Surrey, United Kingdom
• Pfizer Investigational Site — London, United Kingdom
• Pfizer Investigational Site — Nottingham, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.